SMMT Summit Therapeutics, Inc.
Biotechnology NasdaqGM
Trading Signals
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $17.65
- Medium Support $18.64
- Weak Support $19.62
Resistance Levels
- Weak Resistance $21.58
- Medium Resistance $22.56
- Strong Resistance $23.55
Stop Loss Suggestions
- Conservative $21.39
- Moderate $22.07
- Aggressive $23.05
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
Indicator | Signal | Strength | Timeframe |
---|---|---|---|
Moving Averages | NEUTRAL |
|
Short & Medium Term |
Oscillators | SELL |
|
Short Term |
Trend Indicators | BUY |
|
Short & Medium Term |
Volume Indicators | SELL |
|
Short & Medium Term |
Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities
Quarterly Outlook
2025-06-30
Bullish Scenario
from current 42.52%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
2025-06-30
Base Scenario
from current 4.25%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
2025-06-30
Bearish Scenario
from current -42.52%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
Annual Outlook
2025-06-30
Bullish Scenario
from current 85.05%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
2025-06-30
Base Scenario
from current 8.5%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
2025-06-30
Bearish Scenario
from current -85.05%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (30.79) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (49.73) is in bearish territory, indicating downward momentum. MACD line (0.58) is below Signal line (1.14) (bearish crossover), confirming downward momentum. Current Weekly ATR is 4.38, indicating the average weekly price range.
Technical Analysis
Trend Identification
EMA
Exponential Moving Average
Current price (20.60) is between Short MA (20.23) and Long MA (22.90), or near one of them. This suggests consolidation or mixed signals. Short MA (20.23) is below Long MA (22.90), a bearish crossover ('Death Cross' if it's a significant period). This indicates a downward trend. MAs (20.23, 22.90, 21.71) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (0.2000) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). A bullish crossover below the zero line can indicate a reversal from a prior downtrend. Consider this as a potential early buy signal.
ADX
Average Directional Index
ADX (11.96) indicates a weak or non-existent trend (ranging market). -DI (27.60) is above +DI (23.87), suggesting a bearish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI
Relative Strength Index
RSI (46.09) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV
On-Balance Volume
OBV (28630200.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic
Stochastic Oscillator
Stochastics (%K: 67.66, %D: 70.68) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed, potentially signaling a downward trend reversal or continuation. Stronger signal if this occurs above 50.
CCI
Commodity Channel Index
CCI (15.83) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR
Average True Range
Current ATR is 1.5500. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands
Volatility Bands
Current price (20.60) is within the Bollinger Bands (18.21 - 22.25). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (20.23), indicating short-term bullish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals
SAR
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 16.37 is 20.53% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
RSI
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Stochastic
Neutral
Stochastic is in neutral territory (67.7). No clear overbought/oversold signal. Current crossover status: Bearish.
Bollinger Bands
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List (Top 20)
Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
---|---|---|---|---|
Baker Bros. Advisors, LP | INSTITUTIONAL | 24424865 | 3.29% | 2025-03-31 |
Vanguard Group Inc | INSTITUTIONAL | 11640507 | 1.57% | 2025-03-31 |
FMR, LLC | INSTITUTIONAL | 9338223 | 1.26% | 2025-03-31 |
Blackrock Inc. | INSTITUTIONAL | 8397556 | 1.13% | 2025-03-31 |
Price (T.Rowe) Associates Inc | INSTITUTIONAL | 6557804 | 0.88% | 2025-03-31 |
State Street Corporation | INSTITUTIONAL | 4851388 | 0.65% | 2025-03-31 |
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 3496607 | 0.47% | 2025-03-31 |
Geode Capital Management, LLC | INSTITUTIONAL | 3284882 | 0.44% | 2025-03-31 |
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | MUTUALFUND | 2757822 | 0.37% | 2025-03-31 |
SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 2746324 | 0.37% | 2025-04-30 |
Pictet Asset Management Holding SA | INSTITUTIONAL | 2661604 | 0.36% | 2025-03-31 |
iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 2275117 | 0.31% | 2025-04-30 |
Fidelity Select Portfolios-Biotechnology Portfolio | MUTUALFUND | 2158158 | 0.29% | 2025-04-30 |
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 2155435 | 0.29% | 2025-03-31 |
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | MUTUALFUND | 1856977 | 0.25% | 2025-04-30 |
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | MUTUALFUND | 1789347 | 0.24% | 2025-03-31 |
Balyasny Asset Management LLC | INSTITUTIONAL | 1703180 | 0.23% | 2025-03-31 |
Charles Schwab Investment Management, Inc. | INSTITUTIONAL | 1460717 | 0.2% | 2025-03-31 |
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | MUTUALFUND | 911689 | 0.12% | 2025-02-28 |
abrdn Healthcare Investors | MUTUALFUND | 838886 | 0.11% | 2025-03-31 |